主髂动脉闭塞性疾病开放与腔内血运重建后的健康相关生活质量:前瞻性队列研究
单中心前瞻性观察队列纳入2020年1月至2025年7月连续接受开放修复(OpR)或腔内修复(ER)的主髂动脉闭塞性疾病(AIOD)患者,用SF-36在基线及1、6、12个月评估健康相关生活质量(HRQOL)。
要点
- OpR与ER均与AIOD患者HRQOL显著改善相关,ER早期躯体成分改善更快。
- 两组精神成分均随时间改善,组间无差异。
- 早期再干预、晚期并发症、CKD、CAD及截肢与HRQOL改善可能性降低相关。
核心结论
- 开放修复与腔内修复均与AIOD患者HRQOL显著改善相关。
- 腔内修复提供更快的早期躯体恢复,而精神健康结局在两种策略间相当。
- 患者特征和术后不良事件对HRQOL恢复的影响大于血运重建策略本身。
研究设计与样本
- 单中心前瞻性观察队列研究,纳入2020年1月至2025年7月连续接受OpR或ER治疗的AIOD患者。
- HRQOL用SF-36问卷在基线、1、6、12个月评估,比较PCS与MCS评分。
- 采用线性混合效应模型(固定效应为时间、治疗及其交互)比较治疗组间PCS和MCS。
- 线性回归评估基线HRQOL相关因素,Firth惩罚logistic回归评估随访期间HRQOL变化相关因素。
主要发现
- 入组患者中跛行占74.1%、静息痛占13.6%、组织缺损占12.3%,无术后死亡。
- 基线PCS与较高Rutherford分级(P = 0.033)及TASC病变复杂程度(P = 0.02)相关。
- 基线MCS与疾病严重程度(P = 0.018)及合并症(P = 0.048)相关。
- PCS随时间显著改善(P < 0.001),ER组早期改善更快(交互P = 0.005),尤其术后第一个月内(P = 0.011)。
- MCS随时间改善(P = 0.005),组间无差异;早期再干预(PCS P = 0.049)、晚期并发症(PCS P = 0.018;MCS P = 0.031)、CKD(PCS P = 0.012)、CAD(P = 0.014)、截肢(PCS P = 0.049)与HRQOL改善可能性降低相关。
临床怎么用
- 对AIOD血运重建患者应常规关注HRQOL,尤其躯体成分的早期恢复。
- 选择OpR或ER时可告知患者:ER早期躯体恢复更快,但精神健康结局两者相当。
- 合并CKD、CAD及发生早期再干预、晚期并发症或截肢者HRQOL恢复可能更差,需加强随访支持。
局限性
- 非随机分组,治疗选择可能存在混杂。
- 随访至12个月,未报告更长期HRQOL结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To investigate the impact of open repair (OpR) and endovascular repair (ER) on health-related quality of life (HRQOL) in patients treated for aortoiliac occlusive disease (AIOD). METHODS: We conducted a single-center prospective observational cohort study on consecutive patients treated by OpR and ER for AIOD between January 2020 and July 2025. HRQOL was assessed using the 36-Item Short Form Health (SF-36) questionnaire at baseline, 1, 6, and 12 months. Physical component summary (PCS) and mental component summary (MCS) scores were compared between treatment groups using linear mixed-effects models with fixed effects for time, treatment, and their interaction. Linear regression models were used to assess factors associated with baseline HRQOL, while Firth's penalized logistic regression was used to evaluate factors associated with changes in HRQOL during follow up. RESULTS: Eighty-one patients were included: 20 (24.7%) underwent OpR and 61 (75.3%) ER for claudication (74.1%), rest pain (13.6%), or tissue loss (12.3%). No postoperative mortality occurred. Baseline PCS was associated with higher Rutherford class (P = 0.033) and TransAtlantic Inter-Society Consensus (TASC) lesion complexity (P = 0.02), while baseline MCS was associated with disease severity (P = 0.018) and comorbidities (P = 0.048). PCS improved significantly over time (P < 0.001), with a faster early improvement in the ER group (P for interaction = 0.005), especially within the first month from the procedure (P = 0.011). MCS also improved over time (P = 0.005), with no differences between groups. Early reintervention (P = 0.049 for PCS), late complications (P = 0.018 for PCS; P = 0.031 for MCS), chronic kidney disease (CKD) (P = 0.012 for PCS), coronary artery disease (CAD) (P = 0.014), and limb loss (P = 0.049 for PCS) were associated with reduced likelihood scores of HRQOL improvements at follow up. CONCLUSION: Both OpR and ER were associated with significant improvements in HRQOL. ER provided faster early physical recovery, whereas mental health outcomes were comparable between treatment strategies. Patient characteristics and postoperative adverse events had a greater influence on HRQOL recovery than the revascularization strategy itself.
引用
- Squizzato F, Colacchio EC, Menara S, et al. Health-Related Quality of Life after Open and Endovascular Revascularization for Aortoiliac Occlusive Disease: A Prospective Cohort Study. Ann Vasc Surg. 2026. PMID: 42833583. doi:10.1016/j.avsg.2026.09.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。